Novo Nordisk NOVO.B-2.47%decrease; red down pointing triangle expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in applying artificial intelligence to drug discovery – adding up to nine programmes to the ...

Lori Vallow was back in a Phoenix courtroom on Jan. 10 for a status conference. Vallow is accused of conspiring in the fatal shooting of her fourth husband and the attempted murder of her niece's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The collaboration now encompasses additional drug programmes. Credit: aslysun/Shutterstock. Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, ...